Slideshow
Author(s):
Two new studies shed light on risk factors for stroke and MI, and a third suggests neurologic use s for Zolpidem that don’t involve treating insomnia.
Breaking Down ISC 2025: Key Takeaways From Experts in Stroke Neurology
Episode 109: AB126, Exosomes, and Cerebroprotection for Stroke
Mild Electrical Brain Stimulation Fails to Boost Poststroke Recovery in Phase 2 Study
Episode 105: Recapping Conversations in Neurology From 2023
Updates in Therapeutic Development: Clinical Trial Readouts to Watch in the First Half of 2025
NeuroVoices: Daniel Harrison, MD, on Defining APP Competencies in Neurocritical Care Teams